CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 175 enrolled
Drug / intervention
DISC-MVP +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05948670
NCT05948670N/ACompleted
CompareCT.gov

An Exploratory Randomized Controlled Trial of Participant Satisfaction With the BUILD Mobile Application

Woebot Health·interventional·Posted Jul 17, 2023·Updated Feb 18, 2025

In Brief

A clinical study evaluating DISC-MVP and DISC-CON for Satisfaction, Personal. Completed, enrolled 175 participants across 1 site.

Detailed Summary

This study explores user satisfaction with the BUILD mobile application.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSatisfaction, Personal
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJul 17, 2023
Enrollment StartOct 4, 2023
Primary CompletionNov 15, 2023
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 3.0 years ago

Interventions

DISC-MVPdevice

DISC-MVP is a digital program grounded in validated psychotherapies (e.g., cognitive behavioral therapy), that enlists a relational agent (Woebot) to engage users in therapeutic conversations and generates responses through a controlled process using large language models.

DISC-CONdevice

DISC-CON is a digital program grounded in validated psychotherapies (e.g., including cognitive behavioral therapy) that uses a virtual relational agent (Woebot) to engage users in therapeutic conversations with responses that are selected from a list based on natural language processing.